Diagnosis of Alzheimer's disease (AD) is currently largely based on the presence of biomarkers. This may lead to a ...

Alzheimer's is generally characterised by memory loss and other cognitive abilities serious enough to interfere with daily ...

Nearly 7 million Americans have Alzheimer's disease, and this number is predicted to double by 2060. While aging and genetic predisposition are the most important risk factors for Alzheimer's, ...

Researchers from the International Working Group recommend categorizing biomarker-positive, cognitively normal individuals as ...

Anavex announced new data from their phase 2b/3 Alzheimer's trial, which was presented at the CTAD 2024 conference. Read why ...

A study has shone a light on one crucial supplement that may boost brain function among older adults in just a matter of ...

The chelator deferiprone (Ferriprox) decreased brain iron accumulation but accelerated cognitive deterioration in early ...

Dr Lotte Knudson, a scientist from Copenhagen, revolutionized research into drugs used by millions to lose weight. She has ...

Most people associate memory loss with Alzheimer's. But research suggests it may not be the first sign - a systematic review ...

November is Alzheimer's Awareness Month, and if you have a loved one in the beginning stages of the disease, a local clinical ...

In people with mild cognitive impairment, galantamine, compared to placebo, may make little to no difference in improving memory or the ability to do self-care activities. However, participants who ...